Pancreatic cancer is a grim diagnosis, with a five-year survival rate of less than 9 percent. To improve those odds, researchers at UPMC and the University of Pittsburgh School of Medicine sought genetic signatures in the largest study of its kind that could be used to better match drugs to patients and for early detection.
You may also like
Marcia Cross of 'Desperate Housewives' Opens Up on Anal Cancer
- April 21, 2019
(MedPage Today) — ActressRead more
GAP Regimen Tops Historical Data for Advanced Biliary Tract Ca
- April 20, 2019
(MedPage Today) — ResultsRead more